glp-1 receptor agonists mechanism of action of [25] Evolution of GLP‐1 Receptor Agonists
Description
The key secondary endpoints demonstrated significant reductions in atherogenic lipid levels and liver stiffness over 52 weeks in the 80 mg and 100 mg resmetirom
![glp-1 receptor agonists mechanism of action of [25] Evolution of GLP1 Receptor Agonists](https://www.biochempeg.com/usr/uploads/3/202209/Biological-actions-of%20-GLP-1.png)
Overall, a new era in obesity care is starting, as multiple effective obesity pharmacotherapies with different mechanisms of action and routes of administration may become available over next years
![glp-1 receptor agonists mechanism of action of [25] Evolution of GLP1 Receptor Agonists](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-014-0142-7/MediaObjects/12933_2014_Article_142_Fig2_HTML.jpg)
[DOI] [PMC free article] [PubMed] [Google Scholar] 108.Regmi A, Aihara E, Christe ME, Varga G, Beyer TP, et al
![glp-1 receptor agonists mechanism of action of [25] Evolution of GLP1 Receptor Agonists](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-024-01931-z/MediaObjects/41392_2024_1931_Fig5_HTML.png)
Shaikh H., Bradhurst P., Ma L
![glp-1 receptor agonists mechanism of action of [25] Evolution of GLP1 Receptor Agonists](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)